IMMUNIC, INC. (IMUX) › Shareholders' EquityIMMUNIC, INC. (IMUX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: -$54.85M2012: -$7.63M2013: -$44.66M2014: $97.56M2015: $82.33M2016: $58.45M2017: -$13.34M2018: -$25.74M2019: $58.36M2020: $158.78M2021: $127.11M2022: $113.68M2023: $28.93M2024: $18.43M2025: -$6.67M-$6.67M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$6.67M-136.2%2024$18.43M-36.3%2023$28.93M-74.6%2022$113.68M-10.6%2021$127.11M-19.9%2020$158.78M+172.1%2019$58.36M+326.7%2018-$25.74M-93.0%2017-$13.34M-122.8%2016$58.45M-29.0%2015$82.33M-15.6%2014$97.56M+318.5%2013-$44.66M-485.1%2012-$7.63M+86.1%2011-$54.85M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share